Enrolling by Invitation
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
NCT04798430
- Conditions
- Cardiovascular Disease With Mention of Arteriosclerosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +12 more
- Locations
-
- NorthShore University Health System Evanston, Illinois, United States
- Sterling Research Group Cincinnati, Ohio, United States
- The Lindner Research Center Cincinnati, Ohio, United States
- Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States